NRC-2694

N/A

Report date: 2026/04/30 20:00:20
NME

Base Information

Drug NameNRC-2694
Drug Alias NameNRC-2694ANRC-2694NRC-2694-A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEpidermal growth factor receptor erbB1 inhibitors
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsCarcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesIndia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNatco Pharma
China Registration ClassN/A

Develop Information

Active CompaniesNatco Pharma Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A